Ardissino, D., MD, Caballini, C., MD, Bramucci, E., MD, Indolfi, C., MD, Marzocchi, A., MD, Manari, A., MD, et al. (2004, December 8). Sirolimus-Eluting vs Uncoated Stents for Prevention of Restenosis in Small Coronary Arteries. JAMA, 292(22), 2727-2734.
Artang, R., MD, & Dieter, R., MD. (2007, 23 Ferbruary). Analysis of 36 Reported Cases of Late Thrombosis in Drug-Eluting Stents Placed in Coronary Arteries. The American Journal of Cardiology, pp. In Press, Uncorrected Proof.
Bavry, A., MD, Kumbhani, D., MD, Helton, T., DO, Borek, P., MD, Mood, G., MD, & Bhatt, D., MD. (2006, December). Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials. The American Journal of Medicine, 119(12), 1056-1061.
Boston Scientific. (2007). In Resources for Healthcare Professionals (Patient Information Guide - TAXUS Express 2 Paclitaxel-Eluting Coronary Stent System). Retrieved 27 July 2007, from www.taxus-stent.com
Cohen, B. (2006, 30 October). Angioplasy.org. In Drug Eluting Stents. Retrieved 29 July 2007, from Venture Digital: http://www.ptca.org.
Cohen, B. (2006, 30 November). The Voice in the Ear (The Catch-22 of Plavix and the FDA). Retrieved 28 April 2007, from http://http://www.ptca.org/voice/archives/2006_1130.html.
Daemen, J., MD, Tanimoto, S., MD, Garcia, H., MD, Kukreja, N., MRCP, Sianos, G., MD, Jaegere, P., MD, et al. (2007, 6 March). Comparison of Three-Year Clinical Outcome of Sirolimus- and Paclitaxel-Eluting Stents Versus Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology.
Daemen, J., MD, Wenaweser, P., MD, Tsuchida, K., MD, Abrecht, L., MD, Vaina, S., MD, Morger, C., MD, et al. (2007, 2 March). Early and Late Coronary Stent Thrombosis of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Rountine Clinical Practice: Data from a Large Two-Institutional Cohort Study. The Lancet, 369(9562), 667-678.
Ellis, S., MD, Colombo, A., MD, Grube, E., MD, Popma, J., MD, Koglin, J., MD, Dawkins, K., MD, et al. (2007, 13 March). Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent: A TAXUS II, IV, V and VI Meta-Analysis of 3445 Patients Followed for Up to 3 Years. Journal of the American College of Cardiology, 49(10), 1043-1051.
FDA Heart Health Online. (2006, 7 December). In Questions and Answers on Coronary Drug-Eluting Stents. Retrieved 27 July 2007, from http://www.fda.gov/hearthealth/treatments/medicaldevices/stentqa.html.
FDA Heart Health Online. (2006, December 8). In Stent. Retrieved 29 July 2007, from http://www.fda.gov/hearthealth/treatments/medicaldevices/stent.html.
Homes, D., MD, Teirstein, P., MD, Satler, L., MD, Sketch, M., MD, O'Malley, J., PhD, Popma, J., MD, et al. (2006, March 15). Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare Metal Stents: The SISR Randomized Trial. JAMA, 295(11), 1264-1273.
Kasper, D., MD, Braunwald, E., MD, Fauci, A., MD, Hauser, S., MD, Longo, D., MD, & Majeson, J., MD. (2005). Harrison's Principles of Internal Medicine Sixteenth Edition. New York, New York: The McGraw-Hill Companies, Inc.
Kastrati, A., MD, Mehilli, J., MD, Beckerath, N., MD, Dibra, A., MD, Hausleiter, J., MD, Pache, J., MD, et al. (2005, January 12). Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis. JAMA, 293(2), 165-171.
Lichtenstein, A., Appel, L., Brands, M., Carnethon, M., Daniels, S., Franch, H., et al. (2006). Diet and Lifestyle Recommendations Revision 2006; A Scientific Statement From the American Heart Association Nutrition Committee http://circ.ahajournals.org/cgi/reprint/114/1/82.
Little, F., MD. (2007, 5 April). MedlinePlus. In Stent. Retrieved 27 April 2007, from A.D.A.M.: http://www.nlm.nih.gov/medlineplus/ency/article/002303.htm.
Morice, M., MD, Colombo, A., MD, Meier, B., MD, Serruys, P., MD, Tamburino, C., MD, Guagliumi, G., MD, et al. (2006, February 22). Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions, The REALITY Trial: A Randomized Controlled Trial. JAMA, 295(8), 895-904.
Park, D., MD, Park, S., MD, Lee, S., MD, Kim, Y., MD, Lee, C., MD, Hong, M., MD, et al. (2007, 15 March). Frequency of Coronary Arterial Late Angiographic Stent Thrombosis (LAST) in the First Sex Months: Outcomes With Drug-Eluting Stents Versus Bare Metal Stents. The American Journal of Cardiology, 99(6), 774-778.
Pfisterer, M., MD, Rocca, H., MD, Buser, P., MD, Richenbacher, P., MD, Hunziker, P., MD, Mueller, C., MD, et al. (2006, 19 December). Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents: An Observational Study of Drug-Eluting Versus Bare-Metal Stents. Journal of the American College of Cardiology, 48(12), 2584-2591.
Physical Activity for Everyone. (2007, May 22). Retrieved August 2 2007, from Centers for Disease Control and Prevention: http://www.cdc.gov/nccdphp/dnpa/physical/recommendations/index.htm.
Radiology Info. (2005, August 22). In Angioplasty and Vascular Stenting. Retrieved 29 April 2007, from RSNA: http://www.radiologyinfo.org/en/pdf/angioplasty.pdf.
Sandhu, G., MD, Doyle, B., MD, Singh, R., MD, Bell, M., Bresnahan, J., MD, Mathew, V., MD, et al. (2007, 15 February). Frequency, Etiology, Treatment, and Outcomes of Drug-Eluting Stent thrombosis During One Year of Follow-Up. The American Journal of Cardiology, 99(4), 465-469.
Sherwood, L. (2004). Human Physiology From Cells to Systems. West Virginia: Belmont, California: Brooks/Cole.
Steinberg, D., MD, Mishra, S., MD, Javaid, A., Slottow, P., MD, Buch, A., MD, Roy, P., MD, et al. (2007, 1 March). Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (> 3.5 mm) Coronary Arteries. The American Journal of Cardiology, 99(5), 599-602.
Stent Procedure. (2007). Retrieved 2 August 2007, from American Heart Association: http://www.americanheart.org/presenter.jhtml?identifier=4721.
Stone, G., MD, Ellis, S., MD, Cannon, L., MD, Mann, J., MD, Greenberg, J., MD, Spriggs, D., MD, et al. (2005, September 14). Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease. JAMA, 294(10), 1215-1223.
Stone, G., MD, Ellis, S., MD, O'Shaughnessy, C., MD, Martin, S., MD, Satler, L., MD, McGarry, T., MD, et al. (2006, March 15). Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents: The TAXUS V ISR Randomized Trial. JAMA, 295(11), 1253-1263.
TAXUS Express - Paclitaxel-Eluting Coronary Stent System. (2005). Retrieved 7/29/07, from Boston Scientific Corporation: http://www.bostonscientific.com/templatedata/imports/collateral/Coronary/guid_taxexp_01_us.pdf.
The Free Dictionary. (2007). Retrieved 2 August 2007, from Farlex: http://www.thefreedictionary.com.
U.S. Food and Drug Administration. (2006, September 14). Retrieved August 2 2007, from Department of Health and Human Services: http://www.fda.gov/cdrh/news/091406.html
Image References
